Cyanobacteria for environmental, energy and biomedical application: a review
Xiaoya Ren,
No information about this author
Mengqi Feng,
No information about this author
Meiyi Mao
No information about this author
et al.
Environmental Chemistry Letters,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 12, 2025
Language: Английский
Characterization of Bioactive Metabolites in Phormidium sp. PB21: Pigment Production, Antimicrobial Potential, and Toxicity Assessment
Prasannabalaji Nainangu,
No information about this author
K Keerthiga,
No information about this author
Kumaran Subramanian
No information about this author
et al.
Chemistry & Biodiversity,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 10, 2025
ABSTRACT
This
study
investigates
the
morphological
characteristics,
pigment
production,
antimicrobial
activity,
and
toxicity
of
secondary
metabolites
from
filamentous
cyanobacterium
Phormidium
sp.
PB21,
isolated
freshwater
ecosystems.
The
strain
demonstrated
significant
potential
for
bioactive
compound
as
evidenced
by
its
chlorophyll‐
a
carotenoid
production.
Chlorophyll‐
levels
increased
at
0.071
mg/mL
day
24,
reflecting
robust
photosynthetic
while
content
reached
maximum
1.6
under
controlled
conditions,
highlighting
pigment‐based
applications.
Antimicrobial
assays
using
methanol:
chloroform
(1:3)
crude
extracts
revealed
inhibition
human
pathogens,
including
Serratia
(12
mm)
Pseudomonas
aeruginosa
(11
mm),
with
minimum
inhibitory
concentrations
low
15.6
µg/mL
specific
fractions.
Toxicity
assessment
Artemia
salina
indicated
dose‐dependent
effects,
LC
50
values
93
82
fractions
3
4,
respectively,
suggesting
natural
agents.
gas
chromatography‐high‐resolution
mass
spectrometry
analysis
sample
identified
key
compounds,
decanoic
acid,
5‐acetoxytridecane,
1‐undecanol,
based
on
their
characteristic
m/z
values.
These
compounds
exhibit
antimicrobial,
anti‐inflammatory,
pharmacological
properties,
sample's
promising
therapeutic
industrial
findings
emphasize
biotechnological
particularly
in
production
Language: Английский
Inducible Mtld expression facilitated the introduction of the mannitol synthesis pathway in Synechococcus elongatus PCC 7942
Jiahui Sun,
No information about this author
Jinyu Cui,
No information about this author
Xuejing Xu
No information about this author
et al.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2025,
Volume and Issue:
13
Published: March 21, 2025
Mannitol
is
a
valuable
sugar
alcohol,
extensively
used
across
various
industries.
Cyanobacteria
show
potential
as
future
platforms
for
mannitol
production,
utilizing
CO
2
and
solar
energy
directly.
The
proof-of-concept
has
been
demonstrated
by
introducing
two-step
pathway
in
cyanobacteria,
converting
fructose-6-phosphate
to
mannitol-1-phosphate
sequentially
mannitol.
However,
recombinant
strains
generally
faced
issues
of
genetic
instability
or
low
titers,
consequently
affecting
the
long-term
production.
In
this
work,
construction
strategy
engineering
production
Synechococcus
elongatus
PCC
7942,
based
on
commonly
adopted
comprising
dehydrogenase
(Mtld)
mannitol-1-phosphatase
(M1Pase),
was
optimized.
results
that
sequential
introduction
m1p
mtld
required
obtain
mannitol-producing
strains.
We
further
manipulated
abundances
Mtld
with
theophylline
dose-responsive
riboswitch
approach,
combining
it
overexpression
,
we
successfully
obtained
strain
producing
1.5
g/L
under
optimal
conditions,
highest
cyanobacterial
yield
date.
addition,
controlled
expression
remarkably
augment
stability
mutant
culturing
circumstances,
which
continued
secrete
after
more
than
months
cultivation
without
addition
theophylline,
biosynthesis
operon
did
not
undergo
any
spontaneous
mutation.
findings
work
provided
novel
insights
into
area
cyanobacteria
metabolism
engineering,
would
inspire
researchers
construct
different
gene
regulatory
strategies
efficient
photosynthetic
biosynthesis.
Language: Английский
Immunomodulatory properties of polysaccharide extract samples from Cyanobacterium sp. Rippka B-1200
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 5, 2024
Cyanobacteria
are
most
abundant
in
aquatic
systems
and
can
grow
freshwater,
saline
or
brackish
water,
cold/hot
springs.
have
attracted
considerable
research
attention
the
last
decade
as
a
potential
source
of
numerous
biological
products
large
quantities,
such
biofuels,
pigments,
polyunsaturated
fatty
acids,
nutraceuticals,
enzymes,
polysaccharides.
Unlike
plant
fungal
polysaccharides,
chemical
composition,
immunomodulatory
activity,
molecular
mechanisms
action
Cyanobacterium
sp.
Rippka
B-1200
polysaccharides
been
studied
much
less.
The
complexity
their
primary
structure
due
to
high
variability
monosaccharides,
diverse
bonds,
presence
substituents
viscosity
made
detailed
structural
studies
cyanobacterial
rare,
which
determines
need
for
analysis
cyanobacteria
biomass
components
identify
active
metabolites
with
promising
activity.
aim
this
study
was
investigate
properties
from
B-1200.
Pharmacological
nutraceutical
value
has
set,
defining
our
study's
scientific
novelty.
As
result,
weight
immunoactive
polysaccharide
(6.0–8.0
kDa)
determined.
shows
that
endopolysaccharide
samples
at
concentration
300
mg/kg
showed
no
significant
effect
(1.60
±
0.15
mg/g),
thymus
mass
index
animals
experimental
group
comparable
control
were
immunosuppressed
cyclophosphamide
(1.15
0.24
mg/g).
When
exopolysaccharide
used
600
mg/kg,
(3.60
0.32
mg/g)
statistically
(without
polysaccharide)
immunosuppression
not
induced
(thymus
3.70
0.25
It
found
also
exhibited
used,
internal
organ
changes
observed
after
immunosuppression.
empirical
results
presented
may
find
application
development
both
pharmaceutical
cosmetic
products.
Language: Английский